Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate.

Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate.
复制标题

DOI:
10.3389/fphar.2020.594574
复制
发表时间:
2020
影响因子:
5.6
通讯作者:
Stec DE
Stec DE
中科院分区:
医学2区
文献类型:
--
作者:
Hinds TD Jr;Creeden JF;Gordon DM;Stec DF;Donald MC;Stec DE

文献摘要

参考文献

被引文献

相似文献

血浆胆红素水平与肝脏脂肪堆积呈负相关,提示胆红素作为治疗非酒精性脂肪性肝病的可能性。在这里,我们使用聚乙二醇化胆红素(胆红素纳米粒)或赋形剂对照组治疗饮食诱导的肥胖非酒精性脂肪性肝病小鼠,以确定其对肝脏脂肪堆积的影响。胆红素纳米粒显著降低肝脏脂肪、甘油三酯蓄积、新生脂肪生成,以及含有极低密度脂蛋白的肝功能障碍标志物天冬氨酸转氨酶和载脂蛋白B100的水平。胆红素纳米粒通过增加PPARβ和酰基辅酶A氧化酶1来改善肝功能,激活肝脏α氧化途径。胆红素纳米粒还显著升高血浆β-羟丁酸酮水平,减少肝脏脂肪堆积。本研究表明,胆红素纳米粒可诱导肝脏脂肪利用,升高血酮,减轻肝脏脂肪变性,为非酒精性脂肪肝开辟了新的治疗途径。
The inverse relationship of plasma bilirubin levels with liver fat accumulation has prompted the possibility of bilirubin as a therapeutic for non-alcoholic fatty liver disease. Here, we used diet-induced obese mice with non-alcoholic fatty liver disease treated with pegylated bilirubin (bilirubin nanoparticles) or vehicle control to determine the impact on hepatic lipid accumulation. The bilirubin nanoparticles significantly reduced hepatic fat, triglyceride accumulation, de novo lipogenesis, and serum levels of liver dysfunction marker aspartate transaminase and ApoB100 containing very-low-density lipoprotein. The bilirubin nanoparticles improved liver function and activated the hepatic β-oxidation pathway by increasing PPARα and acyl-coenzyme A oxidase 1. The bilirubin nanoparticles also significantly elevated plasma levels of the ketone β-hydroxybutyrate and lowered liver fat accumulation. This study demonstrates that bilirubin nanoparticles induce hepatic fat utilization, raise plasma ketones, and reduce hepatic steatosis, opening new therapeutic avenues for NAFLD.
DOI: 10.3390/ijms17122093
发表时间: 2016-12-13
影响因子: 5.6
作者:
Grabacka M;Pierzchalska M;Dean M;Reiss K
通讯作者: Reiss K
DOI: 10.1007/s11695-017-2579-8
发表时间: 2017-08-01
期刊: OBESITY SURGERY
影响因子: 2.9
作者:
Bawahab, Mohammed A.;Assiri, Abdullah S.;Haider, Syed Saleem
通讯作者: Haider, Syed Saleem
DOI: 10.1074/jbc.m111.311662
发表时间: 2011-12-16
影响因子: 4.8
作者:
Hinds, Terry D., Jr.;Stechschulte, Lance A.;Sanchez, Edwin R.
通讯作者: Sanchez, Edwin R.
DOI: 10.1016/j.biomaterials.2017.04.011
发表时间: 2017-07-01
期刊: BIOMATERIALS
影响因子: 14
作者:
Kim, Jin Yong;Lee, Dong Yun;Jon, Sangyong
通讯作者: Jon, Sangyong
DOI: 10.1210/en.2013-1667
发表时间: 2014-03-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Dong, Huansheng;Huang, Hu;Wang, Hongjun
通讯作者: Wang, Hongjun